94170-15-7 Usage
Uses
Used in Pharmaceutical Synthesis:
1-Methylthyl-2-oxo-1,2-dihydropyridine-4-carboxaldehyde is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs and bioactive compounds. Its unique structure allows for the creation of molecules with specific therapeutic properties.
Used in Agrochemical Production:
In the agrochemical industry, 1-Methylthyl-2-oxo-1,2-dihydropyridine-4-carboxaldehyde is utilized as a building block for the production of various agrochemicals, potentially enhancing crop protection and yield through its incorporation into effective formulations.
Used in Fine Chemicals Manufacturing:
1-Methylthyl-2-oxo-1,2-dihydropyridine-4-carboxaldehyde is employed as a component in the manufacturing of fine chemicals, where its complex structure and reactivity are leveraged to produce specialty chemicals for diverse applications.
Used in Biological Research:
1-Methylthyl-2-oxo-1,2-dihydropyridine-4-carboxaldehyde is studied for its potential as an enzyme inhibitor, which could have implications in the development of treatments for various diseases and conditions by modulating specific biochemical pathways.
Check Digit Verification of cas no
The CAS Registry Mumber 94170-15-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,4,1,7 and 0 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 94170-15:
(7*9)+(6*4)+(5*1)+(4*7)+(3*0)+(2*1)+(1*5)=127
127 % 10 = 7
So 94170-15-7 is a valid CAS Registry Number.
94170-15-7Relevant academic research and scientific papers
Substituted phenyl farnesyltransferase inhibitors
-
, (2012/09/25)
Compounds of formula (I) or pharmaceutically acceptable salts thereof, inhibit farnesyltransferase. Methods for making the compounds, pharmaceutical compositions containing the compounds, and methods of treatment using the compounds are disclosed.
Novel B-ring modified combretastatin analogues: Syntheses and antineoplastic activity
Hatanaka, Toshihiro,Fujita, Koichi,Ohsumi, Koji,Nakagawa, Ryusuke,Fukuda, Yumiko,Nihei, Yukio,Suga, Yasuyo,Akiyama, Yukio,Tsuji, Takashi
, p. 3371 - 3374 (2007/10/03)
A series of B-ring modified combretastatin analogues were synthesized and their inhibitory activity against microtubule assembly, cytotoxic activity against Colon 26 adenocarcinoma cancer cell line were evaluated. Among these, pyridone derivative (19) showed strong antimitotic activity and cytotoxicity, along with excellent water-solubility.
